KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Other Non-Current Liabilities (2016 - 2026)

Silicon Laboratories (SLAB) has 16 years of Other Non-Current Liabilities data on record, last reported at $31.1 million in Q1 2026.

  • For Q1 2026, Other Non-Current Liabilities fell 30.51% year-over-year to $31.1 million; the TTM value through Jan 2026 reached $31.1 million, down 30.51%, while the annual FY2026 figure was $31.1 million, 30.51% down from the prior year.
  • Other Non-Current Liabilities reached $31.1 million in Q1 2026 per SLAB's latest filing, down from $37.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $77.0 million in Q1 2022 and bottomed at $31.1 million in Q1 2026.
  • Average Other Non-Current Liabilities over 5 years is $51.1 million, with a median of $49.6 million recorded in 2024.
  • Peak YoY movement for Other Non-Current Liabilities: tumbled 43.59% in 2022, then skyrocketed 44.29% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $49.1 million in 2022, then surged by 44.29% to $70.8 million in 2023, then tumbled by 36.77% to $44.8 million in 2024, then decreased by 17.26% to $37.0 million in 2025, then decreased by 16.01% to $31.1 million in 2026.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $31.1 million in Q1 2026, $37.0 million in Q4 2025, and $39.3 million in Q3 2025.